Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Waldmann

Showing results (21-30 of 363) with videos related to

Pageof 37
Sort By:
Annual Review of Immunology|January 1, 1992
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejectionT A Waldmann
Cellular Immunology|April 15, 1986
The interleukin-2 receptor on malignant cells: a target for diagnosis and therapyT A Waldmann
Clinical Immunology and Immunopathology|November 1, 1991
Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiencyT A Waldmann
Annals of Allergy|August 1, 1977
The 1977 Bela Schick Memorial Lecture: disorders of suppressor cells in the pathogenesis of immunodeficiency, autoimmune and allergic diseases: human disease associated with disorders of an immunological breaking systemT A Waldmann
Environmental Health Perspectives|November 1, 1987
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferationT A Waldmann
Hospital Practice (Office Ed.)|January 15, 1986
Advances in diagnosis of hematologic malignanciesT A Waldmann
JAMA|January 12, 1990
The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference]T A Waldmann
The Journal of Biological Chemistry|February 15, 1991
The interleukin-2 receptorT A Waldmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Lymphokine receptors: a target for immunotherapy of lymphomasT A Waldmann
The Year in Immunology|January 1, 1993
Genetically engineered monoclonal antibodies armed with radionuclidesT A Waldmann
Pageof 37

Showing results (21-30 of 363) with videos related to

Sort By:
Pageof 37
Annual Review of Immunology|January 1, 1992
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejectionT A Waldmann
Cellular Immunology|April 15, 1986
The interleukin-2 receptor on malignant cells: a target for diagnosis and therapyT A Waldmann
Clinical Immunology and Immunopathology|November 1, 1991
Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiencyT A Waldmann
Annals of Allergy|August 1, 1977
The 1977 Bela Schick Memorial Lecture: disorders of suppressor cells in the pathogenesis of immunodeficiency, autoimmune and allergic diseases: human disease associated with disorders of an immunological breaking systemT A Waldmann
Environmental Health Perspectives|November 1, 1987
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferationT A Waldmann
Hospital Practice (Office Ed.)|January 15, 1986
Advances in diagnosis of hematologic malignanciesT A Waldmann
JAMA|January 12, 1990
The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference]T A Waldmann
The Journal of Biological Chemistry|February 15, 1991
The interleukin-2 receptorT A Waldmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Lymphokine receptors: a target for immunotherapy of lymphomasT A Waldmann
The Year in Immunology|January 1, 1993
Genetically engineered monoclonal antibodies armed with radionuclidesT A Waldmann
Pageof 37